Land: Vereinigtes Königreich
Sprache: Englisch
Quelle: VMD (Veterinary Medicines Directorate)
Moxidectin, Triclabendazole
Zoetis UK Limited
QP54AB52
Moxidectin, Triclabendazole
Pour-on solution
POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person
Cattle
Endectocide
Authorized
2012-03-05
Revised: December 2020 AN: 00880/2020 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cydectin TriclaMox 5 mg/ml + 200 mg/ml Pour-on Solution for cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCES: Moxidectin 5.0 mg Triclabendazole 200.0 mg EXCIPIENTS: Butylhydroxytoluene (E321) 5.0 mg For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Pour-on solution. A clear, amber liquid. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In cattle: Treatment of mixed trematode (fluke) and nematode infections and certain arthropod infestations caused by moxidectin and triclabendazole sensitive strains of: Revised: December 2020 AN: 00880/2020 Page 2 of 8 Parasite Adult stage Inhibited stages NEMATODES L4 GASTRO-INTESTINAL NEMATODES: _Haemonchus placei_ ● ● _Ostertagia ostertagi_ ● ● ● _Trichostrongylus axei_ ● ● _Nematodirus helvetianus_ ● ● _Cooperia oncophora_ ● ● _Cooperia punctata_ ● _Oesophagostomum radiatum_ ● _Bunostomum phlebotomum_ ● RESPIRATORY TRACT NEMATODE: _Dictyocaulus viviparus_ ● TREMATODES LIVER FLUKE: 6 – 8 weeks immatures _Fasciola hepatica_ ● ● ECTOPARASITES _Linognathus vituli_ ● _Bovicola bovis_ ● _Solenopotes capillatus_ ● The product has a persistent effect in preventing re-infection by _Ostertagia ostertagi_ and by _Dictyocaulus viviparus_ for 5 weeks after a single dose. 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to the active substance(s) or to any of the excipient(s). 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. Underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack o Lesen Sie das vollständige Dokument